Showing 1 - 2 results of 2 for search 'Brian R. Leyland-Jones', query time: 0.02s Refine Results
  1. 1
    Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]

    Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014... by Pradip De, Yuling Sun, Jennifer H. Carlson, Lori S. Friedman, Brian R. Leyland-Jones, Nandini Dey

    Published 2014-04-01
    Get full text
    Article
  2. 2
    Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness

    Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness by Pradip De, Yuling Sun, Jennifer H. Carlson, Lori S. Friedman, Brian R. Leyland-Jones, Nandini Dey

    Published 2014-01-01
    Get full text
    Article

Search Tools: